BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38039876)

  • 1. Factors associated with unknown primary status in head and neck squamous cell carcinoma.
    Kalavacherla S; Li V; Voora R; Victor M; Faraji F; Guo T
    Oral Oncol; 2024 Jan; 148():106650. PubMed ID: 38039876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer.
    Schroeder L; Pring M; Ingarfield K; Pawlita M; Leary SD; Thomas SJ; Waylen A; Waterboer T; Ness AR
    Oral Oncol; 2020 Aug; 107():104721. PubMed ID: 32361566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
    Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
    Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
    J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.
    Ross RB; Koyfman SA; Reddy CA; Houston N; Geiger JL; Woody NM; Joshi NP; Greskovich JF; Burkey BB; Scharpf J; Lamarre ED; Prendes B; Lorenz RR; Adelstein DJ; Ward MC
    Laryngoscope; 2018 Jun; 128(6):1379-1385. PubMed ID: 29086413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus.
    Ernster JA; Sciotto CG; O'Brien MM; Finch JL; Robinson LJ; Willson T; Mathews M
    Laryngoscope; 2007 Dec; 117(12):2115-28. PubMed ID: 17891052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
    Das LC; Karrison TG; Witt ME; Muller C; Stenson K; Blair EA; Cohen EEW; Seiwert TY; Haraf DJ; Vokes EE
    Ann Oncol; 2015 Jan; 26(1):198-205. PubMed ID: 25361984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Bauwens L; Baltres A; Fiani DJ; Zrounba P; Buiret G; Fleury B; Benzerdjeb N; Grégoire V
    Radiother Oncol; 2021 Apr; 157():122-129. PubMed ID: 33545255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Surgical Margin Distance With Survival in Patients With Resected Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
    Sunkara PR; Graff JT; Cramer JD
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):317-326. PubMed ID: 36821132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
    Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
    J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
    Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
    J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin.
    Yasui T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Inohara H
    PLoS One; 2014; 9(4):e95364. PubMed ID: 24752007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of contralateral-bilateral nodes in the human papillomavirus era.
    Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO
    Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma.
    Yan EZ; Wahle BM; Massa ST; Zolkind P; Paniello RC; Pipkorn P; Jackson RS; Rich JT; Puram SV; Mazul AL
    Cancer Med; 2023 Apr; 12(8):9976-9987. PubMed ID: 36847063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
    Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
    Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.